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Contrast-enhanced ultrasound (CEUS)
of the abdominal vasculature
Vasileios Rafailidis , Cheng Fang, Gibran T. Yusuf, Dean Y. Huang, Paul S. Sidhu
Department of Radiology, King’s College London, King’s College Hospital, Denmark Hill, SE59RS London, England, UK
Abstract
Vascular diseases account for a signiﬁcant proportion of
abdominal pathology and represent a common referral
source for abdominal ultrasonographic examinations.
B-mode, color Doppler, and spectral Doppler analyses
are well-established in the evaluation of abdominal blood
vessels although they may occasionally be limited by
lower sensitivity for slow ﬂow visualization or the deeper
location of abdominal vascular structures. The intro-
duction of microbubbles as ultrasonographic contrast
agents has rendered contrast-enhanced ultrasound
(CEUS), a valuable complementary ultrasonographic
technique, which is capable of addressing clinically sig-
niﬁcant problems and guiding patient management. The
purpose of this pictorial review is to analyze the use of
CEUS in the evaluation of abdominal vascular pathol-
ogy and illustrate such applications by presenting rep-
resentative images. Pathology discussed includes
abdominal aortic aneurysm, post-endovascular treat-
ment aorta, portal vein thrombosis, abdominal vascular
trauma, and organ transplantation along with its com-
plications.
Key words: Contrast-enhanced ultrasound—
Aorta—Portal vein—Aneurysm—Endoleak—Trauma
Ultrasonography (US) is a well-established ﬁrst-line
modality for the evaluation of abdominal symptoms.
Vascular diseases account for a signiﬁcant part of
abdominal abnormalities comprising a wide spectrum of
conditions including arterial and venous diseases, dis-
eases affecting native organs, post-operative surveillance
and detection of complications, benign and malignant
entities, and follow-up of transplantation. Its widespread
use is based on numerous advantages, including low cost,
repeatability, potential to be performed at any location
from the patient’s bedside to the operating room, good
patient tolerability, and the absence of contraindications.
Nevertheless, US has inherent limitations and in some
cases may not successfully address all clinical demands.
Inappropriate body habitus, the presence of overlying
gas-containing intestinal loops, deep position of
abdominal organs, and vascular structures are important
limitations for the ultrasonographic evaluation of
abdominal abnormalities. When it comes to abdominal
vascular diseases, color and power Doppler techniques
along with spectral analysis are essential for diagnosis
but again have inherent limitations like Doppler angle
dependency, limited sensitivity to slow ﬂow, and aliasing
or blooming artifact [1]. These limitations are usually
accommodated by the performing physician but may
hinder proper diagnosis in challenging conditions like the
detection of a small or delayed endoleak or the identifi-
cation of neovascularization within a malignant portal
venous thrombus. Computed tomography angiography
(CTA) and magnetic resonance angiography (MRA) are
currently the reference methods for diagnostic evaluation
of abdominal vascular abnormalities, overcoming US
limitations, and meeting clinical imaging needs. How-
ever, there are situations where CTA and MRA should
be avoided, including patients with renal impairment,
cardiac pacemakers, and metallic foreign bodies. In a
number of patients, US will be the sole imaging modal-
ity.
Recent signiﬁcant technological advances in US with
the introduction of elastography and contrast-enhanced
ultrasound (CEUS) have expanded capabilities, with the
term multiparametric ultrasound (MPUS) used to
encompass all the facets of US [2]. Contrast-enhanced
ultrasound, using microbubble as ultrasonographic
contrast agents (UCA), has gained wide acceptance in
many clinical scenarios, culminating in the publication of
numerous official recommendations [1]. The recent Food
and Drug Administration (FDA) approval for an UCA
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for characterization of focal liver lesions in adult and
pediatric patients is expected to further increase the use
of CEUS in the United States [3]. With regard to
abdominal vascular pathology, CEUS has been investi-
gated in many applications although considered partic-
ularly valuable in the detection and characterization of
aortic endoleaks, identification of aortic dissection and
rupture, and for differential diagnosis of neoplastic vs.
bland thrombus in the portal vein and inferior vena cava
(IVC) [1, 4]. Beyond the unenhanced ultrasonographic
technique’s inherent advantages previously described,
CEUS is also characterized by improved flow visualiza-
tion even in extremely small-caliber vessels, for example,
in tumor neovessels, superior spatial and temporal res-
olution in real-time evaluation, and increased contrast
between blood flow and avascular tissues. This relies on
the unique property of UCA to strictly remain within the
vascular tree, incapable of diffusion through the vessel
wall as their size does not permit this. Moreover, CEUS
advantages include dispensing of any prior laboratory
tests, excellent safety profile, and limited contraindica-
tions [1, 3, 5].
The purpose of this article is to provide an overview
of CEUS applications in abdominal vascular abnormal-
ities based on the current literature, and furthermore to
present characteristic cases where CEUS proved valuable
for diagnosis. The main focus will be in aortic abnor-
malities including abdominal aortic aneurysm and post-
operative surveillance for early detection of endoleaks
and venous pathology including neoplastic thrombosis.
Less widely performed applications will also be detailed,
as summarized in Table 1.
Technique and safety
CEUS is performed with the intravenous administration
of a bolus dose of the UCA, and essentially always
performed after a complete unenhanced ultrasono-
graphic examination. This allows the examiner to iden-
tify the area of interest, establish an initial opinion,
ascertain the viability of a subsequent CEUS examina-
tion and plan the procedure to maximize the diagnostic
outcome. Once the unenhanced ultrasonographic pro-
tocol is complete, having appreciated the gray-scale,
color, power Doppler, and spectral analysis ﬁndings, an
intravenous catheter can be placed in the antecubital
fossa. It is best to insert the intravenous catheter fol-
lowing the baseline US to avoid unnecessary cannulation
if the CEUS examination is not deemed useful. In gen-
eral, the amount of UCA administered varies depending
on the ultrasound machine’s sensitivity and the product
used. SonoVueTM (Bracco SpA, Milan, Italy) is the most
widely used contrast agent in Europe and consists of
microbubbles containing an inert gas (sulfur hexaﬂuo-
ride) encapsulated by a phospholipid shell, marketed as
LumasonTM (Bracco SpA, Milan, Italy) in the United
States. A dose of 2.4 mL of LumasonTM/SonoVueTM per
injection is considered adequate for the liver and other
abdominal vascular procedures. A second dose of
2.4 mL can be administered if needed. UCA are strict
intravascular agents, large enough (10 lm) to preclude
passage through the vascular endothelium, but small
enough to circulate through small capillaries. Crucially,
the metabolism of UCA renders them independent of
renal excretion, the phospholipid shell is metabolized by
the liver and the contained inert gas is exhaled by the
Table 1. Summary of CEUS applications for various abdominal vascular systems
Vascular
system
Applications Specific strengths over CTA
Native aorta Delineation of mural thrombus blood flow within an aneurysm
Detection of active extravasation in ruptured AAA
Detection of aorto-caval fistulas
Detection of aortic dissection
Detection of rupture signs in the emergency department
However, an MDCTA should always be performed when
available
Post-EVAR
aorta
Detection and characterization (classification) of endoleaks
Quantification of aneurysm enhancement
Dynamic evaluation
Prolonged scanning
Better characterization of endoleaks
Lack of nephrotoxic contrast agent and ionizing radiation,
suitable for long-term follow-up
Portal vein Improved detection of portal vein thrombus
Characterization of portal vein thrombosis as benign or
malignant
Increased spatial and temporal resolution within the field-of-
view
Improved detection of neovessels
Renal arteries Improvement of renal arteries evaluation with Doppler
technique
–
Hepatic/me-
senteric
arteries
Improvement of mesenteric artery evaluation –
Trauma Detection of parenchymal injuries
Detection of vascular pathology like pseudoaneurysm or active
bleeding
Real-time evaluation
Prolonged continuous scanning
Transplanta-
tion
Detection of vascular complications like hepatic artery and
portal vein thrombosis or stenosis
Real-time evaluation
Prolonged continuous scanning
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lungs. As a result, CEUS can be safely performed in
patients with renal impairment. In order to achieve
optimal visualization of the UCA, a contrast-speciﬁc
ultrasonographic technique should be applied. Pulse
inversion and amplitude-modulation techniques which in
general suppress echogenic signals originating from static
tissues while visualizing echogenic signals produced by
oscillating microbubbles are used. This results in the
optimal echogenicity distinction between UCA and static
tissues and offers the best spatial and temporal resolu-
tion. Two valuable techniques in vascular CEUS include
the replenishment mode after a high-Mechanical Index
pulse and the Temporal Maximum Intensity Projection
(MIP) mode. In the ﬁrst technique, a high-MI ultrasound
pulse is used to disrupt all the microbubbles lying within
the imaging ﬁeld with replenishment allowing observa-
tion of the enhancement pattern of structures. In the
second technique, the ultrasound device aggregates
bright echoes of the UCA and creates cumulative images
which illustrate the vascular pattern or architecture of
structures under investigation [1, 3, 4, 6].
Among its advantages, CEUS can be performed
without any prior laboratory examination as impaired
renal function is not a contraindication for administra-
tion of UCA, contrary to CTA and MRA. The con-
traindications for CEUS are limited and include known
history of allergic reaction to the UCA itself, severe
pulmonary hypertension and pregnancy. The con-
traindication of right-to-left shunt has been recently
discontinued [1, 7]. SonoVueTM has been extensively
investigated for adverse reactions and has an excellent
safety profile. Serious adverse reactions occurred in only
0.0086% of patients and treatment was necessary in only
four patients. This adverse reaction rate is considered
comparable to the rate of MR contrast agents and lower
than CT contrast agents [1, 8, 9]. CEUS is a safe tech-
nique; however, given the very small likelihood of ad-
verse reactions, resuscitation equipment should be
available in every US Department where CEUS exami-
nations are performed.
Clinical applications
Native aorta
The term abdominal aortic aneurysm (AAA) refers to an
irreversible enlargement of the abdominal aorta of more
than 3 cm or 50% of reference diameter [10]. US is
excellent for screening or diagnostic evaluation and fol-
low-up of AAA with high sensitivity and specificity and
excellent intra- and inter-observer agreement [11]. The
use of UCA adds little to the evaluation of an uncom-
plicated AAA, although it will readily and accurately
delineate mural thrombus and differentiate this from
slow blood flow, often not visualized with conventional
US techniques [1, 4, 12, 13]. Rupture of an AAA; asso-
ciated with high mortality, necessitates early and accu-
rate diagnosis with immediate treatment [10, 14].
Rupture risk increases with increasing aneurysm diame-
ter rising to > 30% for aneurysms larger than 7 cm [10].
Patients presenting with abdominal pain of acute onset
and low blood pressure or decrease of hematocrit may
signify an AAA rupture, and US can exclude the pres-
ence of an AAA. US has limited accuracy for detection
of rupture, [15]. The use of UCA significantly increases
the sensitivity for detection of several findings of AAA
rupture. With the intravascular nature of the UCA,
CEUS is able to visualize active extravasation and
dependent pooling of the UCA in the retroperitoneum or
peritoneal cavity. Although these findings closely corre-
late with those provided by CTA, CEUS has the poten-
tial to be performed at the bedside in the Emergency
Department, prompting accurate diagnosis with earlier
treatment [16, 17].
AAA rupture may rarely be complicated by the for-
mation of an aorto-caval ﬁstula, which needs speciﬁc
management. Although CTA is the reference method for
the evaluation of aorto-caval communications, CEUS
has the potential to delineate such communication with
high accuracy in a real-time and dynamic manner [18,
19]. Arterial-venous communications have also been
demonstrated with UCA in different vascular systems
including the femoral vessels [4].
Dissection usually affects both thoracic and abdom-
inal aorta, with isolated abdominal aortic dissection
being rare [20]. Symptoms like asymmetric blood pres-
sure, pain of acute onset, and signs of organ dysfunction
secondary to ischemia should point toward the diagnosis
Fig. 1. Routine post-elective EVAR follow-up scan from a
83-year-old man showed an expanding aneurysmal sac.
CEUS was performed to look for endoleak. Longitudinal view
of an aortic stent graft within the dilated aneurysm sac (be-
tween short arrows). CEUS image demonstrates microbubble
ultrasound contrast within the patent aortic stent graft with no
evidence of ‘‘endoleak’’ (long arrow).
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of aortic dissection [21, 22]. CTA remains the primary
modality for emergency evaluation of the whole aorta
including the iliac arteries. If US findings are inconclu-
sive but suspicious of dissection, UCA can be used.
Suspicious conventional US findings include an intimal
flap and bidirectional color flow signals within the lumen
of aorta. The administration of UCA readily and accu-
rately visualizes intimal flaps, establishing the diagnosis
of dissection. Moreover, CEUS helps identify re-entry
points and discriminate true and false lumen as the
enhancement of the former precedes that of the later [13,
19, 23–25].
Post-operative aorta
An endovascular approach using vascular stents (En-
dovascular Aneurysm Repair, EVAR) is largely replac-
ing the traditional open surgical repair of AAA. The
endovascular approach needs lifelong imaging surveil-
lance allowing for early detection and management of
complications. EVAR complications include endoleak,
fractures, graft migration, graft disconnection, or pro-
gressive enlargement of the aneurysmal sac. Imaging
surveillance is routinely performed with CTA or US and
is advocated lifelong although increased risk for rupture
occurs for the ﬁrst two to three years after EVAR [26–
30]. US is limited by low sensitivity for flow visualization
while CTA is disadvantaged by iodinated contrast med-
ium and ionizing radiation. CTA provides ‘‘snapshots’’
of blood flow within a stented aorta, whereas CEUS is
characterized by increased sensitivity compared to US,
with continuous scanning of the aneurysmal sac in a
dynamic and real-time pattern, for > 3 min (Fig. 1).
This is useful for characterization of both fast-flowing
and slow-flowing endoleaks. With real-time visualization
and the option to disrupt the UCA and observe the
replenishment pattern, CEUS can accurately characterize
the origin of the endoleak, direction, and extent; infor-
mation essential for type differentiation [4, 31].
Endoleaks represent the presence of blood ﬂow within
the aneurysmal sac but outside the stented vessel lumen
and characterized based on the direction of blood ﬂow
into ﬁve categories [26, 29, 32]. Type 1 endoleak refers to
an endoleak originating from the attachment of the stent
graft with the aortic wall; being proximal (type 1A) or
distal (type 1B) attachment. Type 2 endoleaks are the
most frequent and represent retrograde blood flow from
an anastomotic branch of the aorta or iliac arteries into
the aneurysmal sac. Such anastomotic branches are
usually the inferior mesenteric or the lumbar arteries. If
only one vessel is leaking, the endoleak is classified as
type 2A, whereas if multiple vessels are implicated, the
endoleak is classified as type 2B. Even though this en-
doleak usually resolves spontaneously, increased aware-
ness is necessary as increased blood flow and pressure
may lead to aneurysm sac enlargement and eventually
rupture [26, 29, 30]. Structural failure of the stent may
lead to type 3 endoleak, which describes blood flow
originating from a defect in the stent, the frequency of
this endoleak being proportionate to the stent’s age [26,
29, 33] (Fig. 2; Online Resources 1, 2, 3). Type 4 en-
doleaks results from porosity of the stent wall, immedi-
ately after stent placement or up to 30 days after
intervention (Fig. 3). Type 4 endoleaks constitute a
diagnosis of exclusion, will usually resolve with normal-
ization of coagulation parameters; carrying no clinical
consequence. However, careful characterization is nee-
ded as this may mimic other types of endoleaks [26, 29].
The term endotension refers to the enlargement of an-
eurysm sac without a detectable endoleak, found after a
successful EVAR. Endotension is also characterized as
type 5 endoleak and is considered to be caused by con-
tinuously increased blood pressure within the aneurysm
stent [26, 29].
US offers a cost effective, well-tolerated option for
imaging surveillance of the post-EVAR aorta, but lim-
ited by body habitus, operator experience, and technical
artifacts. The diagnostic accuracy varies; studies report-
ing a 45% positive predictive value and 86% sensitivity
for endoleak detection [34] with US detecting more en-
doleaks requiring intervention compared to CT, with a
90% sensitivity and 81% specificity [35], compared to
color Doppler with a sensitivity of 33%–63% and speci-
ficity of 63%–93% [36, 37].
CEUS has been widely investigated for accuracy in
detecting endoleaks. OptisonTM (Mallinckrodt, St Louis,
Mo) was found to accurately classify endoleaks as type 1
or 2, enabling US to detect more endoleaks than delayed-
phase CTA [38]. The diagnostic accuracy of CEUS with
OptisonTM for the diagnosis of endoleaks is reported at a
sensitivity of 100% and specificity of 65% [39]. CEUS
with SonoVueTM has demonstrated variable results, with
a sensitivity of 80%–100% and a specificity of 82%–100%
in diagnosing endoleaks, outperforming color Doppler
US [36, 37, 40–42]. Some studies have concluded that
CEUS may even outperform CTA, the current gold
standard for evaluation of endoleaks, primarily
attributable to the dynamic and real-time nature of
imaging [42]. According to a meta-analysis, CEUS
pooled sensitivity and specificity for diagnosis of en-
doleak is 91.4% and 78.2%, respectively, although sig-
nificant heterogeneity of studies was noted, potentially
limiting the accuracy for specificity [43]. Beyond subjec-
tive assessment of endoleak presence, CEUS also pro-
vides the potential for objective quantitative analysis of
aneurysmal sac enhancement. Studies using time–inten-
sity curves have demonstrated that CEUS is 99% sensi-
tive and 93% specific for detection of endoleaks,
compared with CTA, with a significant difference be-
tween the enhancement level of aneurysms with and
without endoleak [44]. If a four-dimensional technique is
applied, CEUS has equivalent accuracy to CTA for
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Fig. 2. Longitudinal views of aortic stent grafts demon-
strates type 1 (row A), type 2a (row B), and type 3 (row C)
endoleaks. Each row consists of sequential CEUS images
(left to right) demonstrating UCA jets (long arrows) originating
from the aortic stent grafts from ineffective proximal seal (row
A, type 1), persistent filling of the aneurysmal sac from the
inferior mesenteric artery (row B, type 2a), and inadequate
sealing of the overlapping main aortic body and iliac stent (row
C, type 3). The aneurysmal sac is filled with UCA (broken
arrows) with central thrombosis (short arrows).
Fig. 3. Longitudinal views of aortic graft. Sequential CEUS images (A–C) demonstrates UCA jets (arrows) originating through
the stent graft resulting in a type 4 endoleak due to porosity of the stent graft fabric.
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evaluation of post-operative aortic aneurysm diameter,
volume, and endoleak detection in patients with fenes-
trated endografts [45]. According to a systematic review,
CEUS and MRA have superior diagnostic accuracy
compared to CTA for identification of post-EVAR en-
doleaks, although being equivalent to CTA for charac-
terization of endoleaks type 1 and 3 [46]. CEUS was also
found to outperform CTA for the diagnosis of delayed
type II endoleak [43].
In conclusion, CEUS offers a beneﬁcial alternative to
CTA especially for patients with impaired renal function.
Moreover, CEUS is also a suitable alternative for
younger patients with EVAR reducing the cumulative
exposure to ionizing radiation, with the need for lifelong
imaging surveillance with CTA. CEUS could be incor-
porated in diagnostic algorithms for the detection of
endoleak as a second step after initial US examination, in
order to increase the technique’s diagnostic accuracy. In
cases of negative results, the patient could be safely dis-
charged and referred for follow-up imaging. Further
imaging with CTA could be reserved for cases with
positive results or continued suspicion of endoleak [28,
31, 36, 47].
Portal vein thrombosis
Portal vein thrombosis may be bland or neoplastic, in
patients with hepatocellular carcinoma and cirrhosis.
Accurately characterizing portal vein thrombus as neo-
plastic or bland is of clinical signiﬁcance as the former
constitutes a contraindication for liver transplantation.
Fig. 4. Patient with history
of invasive retroperitoneal
sarcoma compressing on
IVC which was resected
(surgical clips, open arrow).
She subsequently
presented with bilateral
lower limb pitting edema.
Imaging studies were
performed to exclude IVC
thrombus (A) coronal CECT
(B) Color Doppler US and
(C) Gray-scale US
demonstrate near occlusive
thrombus within the IVC
(arrows). (D) The thrombus
shows enhancement with
microbubble ultrasound
contrast imaging in keeping
with tumor thrombus
(arrow).
Fig. 5. CEUS image demonstrates non-occlusive bland
thrombosis of the left portal vein (arrows).
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Characterization of thrombus as neoplastic can be
established on the presence of neovascularization within
the thrombotic material. Benign thrombosis manifests
with shrinkage of the thrombus or recanalization of the
portal vein, seen with color Doppler US, on follow-up
examination, whereas increase in thrombus size, disrup-
tion of the vessel wall, and inﬁltration of the adjacent
liver parenchyma is in keeping with malignancy [48].
B-mode US is useful in detecting portal vein thrombosis
but is unreliable in differentiating benign from malignant
thrombus. Color Doppler US can be useful by demon-
strating color flow signals within the thrombus although
less effectively for small thrombus. A deep location of the
portal vein and a potentially unfavorable body habitus
may limit sensitivity for detection of neovascularization.
CEUS is superior to color Doppler technique for the
diagnosis of neoplastic portal vein thrombosis in patients
with liver cirrhosis. CEUS has the ability to visualize
pulsatile enhancement of portal vein thrombus during
the arterial phase, preceding portal lumen enhancement,
representing malignant neovascularization [49–54].
CEUS provides conclusive outcomes in > 97% of pa-
tients examined, with no further imaging required [51]. In
terms of diagnostic accuracy, CEUS was found to be
100% sensitive, 66.7% specific, and 93.3% accurate in the
diagnosis of malignant portal venous thrombosis [48].
With the introduction of CEUS in the diagnostic strategy
of malignant portal vein thrombosis, fewer interven-
tional fine-needle biopsies are required, which is con-
sidered the reference method, and less well-tolerated by
the patients [53]. CEUS can also be used to characterize
thrombus within other abdominal veins like the hepatic
and inferior vena cava (Fig. 4). Moreover, it can accu-
rately detect non-occlusive portal vein thrombus (Fig. 5)
and establish the patency of portal vein in cases with
slow flow not visualized on color Doppler technique
(Fig. 6).
Abdominal trauma
CEUS in abdominal trauma has been evaluated with
promising results. Traumatic parenchymal lesions appear
as non-enhancing hypoechoic areas and showing vari-
ance with the otherwise normally perfused parenchyma.
CEUS can readily identify and characterize lacerations,
contusions, and intra-parenchymal or sub-capsular he-
matomas affecting all solid organs of the abdominal
cavity. Based on studies comparing US and CEUS with
CT as the reference standard in patients sustaining blunt
abdominal trauma, CEUS was found to outperform US
in terms of sensitivity and speciﬁcity for the diagnosis of
solid organ injury, with CEUS demonstrating 69% sen-
sitivity and 99% speciﬁcity for diagnosing renal trauma,
84% sensitivity and 99% speciﬁcity for liver trauma, and
93% sensitivity and 99% speciﬁcity for splenic trauma [1,
55, 56].
Beside characterization of parenchymal injuries,
CEUS is particularly valuable for detection of vascular
abnormalities not visualized with the unenhanced
Fig. 6. A 66-year-old male with liver cirrhosis developed
hepatorenal syndrome. Color Doppler US failed to demon-
strate the presence of portal flow likely due to slow flow (A,
arrow). CEUS was performed instead of CECT due to poor
renal function. CEUS demonstrated a patent portal vein (B,
arrows). Isolated CEUS image from the same patient shows
recanalisation of large umbilical vein (C, arrows) surrounded
by large volume ascites (black area) in keeping with estab-
lished portal hypertension.
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B-mode US. These abnormalities include parenchymal
infarcts, arterial pseudoaneurysms, and active hemor-
rhage [1, 56, 57] (Fig. 7). The extravasation of UCA
represents foci of active hemorrhage and has been re-
ported in splenic, liver, and renal trauma. UCA
extravasation may be visualized as rounded echogenic
pools or as fountain-like echogenic jets [17].
Transplantation
US is routinely performed for monitoring of trans-
planted organs during the post-operative period for early
detection of complications, including arterial occlusion
or stenosis and venous thrombosis. The unenhanced
techniques of B-mode, color Doppler, and spectral
analysis are an invaluable tool for screening for these
complications. However, sensitivity is limited with
inconclusive results. Further imaging is often warranted
either with a non-invasive type of angiography (CTA or
MRA) or with interventional angiography. CEUS is
well-established for the evaluation of both micro-vascu-
lature and macro-vasculature, acting as a potential
alternative to CTA or MRA.
It has been established that the administration of
UCA increases the diagnostic accuracy of US for the
detection of ischemic areas of both native and trans-
planted organs, demonstrating areas of ischemia with
increased tissue contrast, depicted as non-enhancing
areas within the normally perfused parenchyma. Color
Doppler provides only a subjective assessment of tissue
vascularity based on the color ﬂow signals [58–61].
CEUS is useful for assessment of liver transplantation
complications including hepatic artery and portal vein
occlusion and stenosis, active hemorrhage, pseudoa-
neurysm formation, and parenchyma infarction. The
intravenous administration of UCA provides real-time
evaluation of tissue perfusion and detailed vascular
opaciﬁcation, offering greater conﬁdence for the per-
forming physician and facilitating the visualization of
patent, occluded, or stenotic hepatic arteries (Fig. 8).
CEUS may obviate the need for interventional angiog-
raphy in > 60% of patients [62–66] and is 92.3% sensi-
Fig. 7. A 14-year-old boy
fell downstairs and
sustained a grade 4 liver
laceration. CECT (axial)
shows linear area of liver
laceration (A, arrow). CEUS
of the liver was performed
5 days post-trauma to
evaluate the injury.
Sequential CEUS images
(B and C) demonstrate a
pseudoaneurysm (arrow in
B, between cursors and
arrow in C). Image B is
taken during arterial phase
akin to the CT angiographic
phase with microbubble
contrast only seen in the
hepatic artery and
pseudoaneurysm. The later
image C shows the
presence of microbubble
contrast within the liver. The
part of the liver which lacks
microbubble contrast
correspond to area of liver
laceration. The
pseudoaneurysm was
confirmed during
conventional hepatic artery
catheter angiography (D,
arrow) and subsequently
successfully embolized with
vascular coils.
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tive and 87.5% specific for the diagnosis of hepatic artery
stenosis, correcting false-positive results found on color
Doppler. CEUS may be introduced in a diagnostic
algorithm following color Doppler US for evaluation of
liver transplant vasculature, with positive findings on
CEUS warranting investigation with angiography [67].
Fig. 8. A 60-year-old
female developed hepatic
artery thrombosis post-liver
transplantation. The CEUS
(A) and axial CECT
(B) comparison images
demonstrate proximal
hepatic artery thrombosis
(solid arrow) with lack of
microbubble ultrasound
contrast or iodinated
contrast vascular
enhancement. The coeliac
trunk is labeled as CEL and
the splenic artery is
indicated by open arrows.
There is widespread
resultant geographical areas
of hepatic infarction present
on the CECT and CEUS
images (arrows, C and D).
Fig. 9. CEUS and CECT
images from two cases of
splenic artery
pseudoaneurysm formation
(arrows). A (CEUS) and
B (CECT, axial) from a
47-year-old male who
developed splenic artery
pseudoaneurysm encased
by necrotising pancreatitis
with large peripancreatic
collection and completely
infarcted non-enhancing
spleen. C (CEUS) and
D (CECT, coronal) from a
43-year-old male who
suffered blunt abdominal
trauma demonstrates a
small peri-splenic
hematoma (broken arrows)
and a pseudoaneurysm
(arrow) adjacent to the
laceration (open arrow).
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CEUS following renal transplantation can be used to
identify acute cortical necrosis, demonstrating the
peripheral rim sign, as seen on CT and MR imaging [68].
Functional information related to the transplanted kid-
ney can be obtained with quantification of parenchymal
signal intensity on CEUS. This technique produces time–
intensity curves and dynamic variables like time-to-peak
and peak intensity. Good inter-observer agreement was
demonstrated with this type of analysis, while the
quantitative variables obtained have been correlated with
glomerular filtration rate 3 months after transplantation
[69].
Other abdominal vessels
Renal and mesenteric arteries represent a challenging
arterial system for US evaluation due to their deep
location, tortuous course, and overlying bowel gas. Re-
cent technological advances and widespread availability
of CTA or MRA have replaced interventional angiog-
raphy for evaluation of renal and mesenteric artery
stenosis. CEUS is able to accurately detect and delineate
aneurysms affecting virtually any blood vessels visualized
with US (Fig. 9). Moreover, CEUS may play an
important role in the post-interventional management of
such patients; identifying residual flow within aneurysms
or establishing their successful embolization (Fig. 10).
The use of UCA may be expected to increase accuracy
for evaluation, but there is limited literature available [1].
The administration of LevovistTM (Schering, AG,
Berlin), a ﬁrst-generation UCA, allowed for quicker
evaluation of intrarenal arteries Doppler spectrum with
superior sensitivity and speciﬁcity compared to the
unenhanced technique [70]. The administration of UCA
can be used to aid correct placement of the sample vol-
ume during pulsed-wave Doppler interrogation of the
renal arteries, increasing the technique’s sensitivity [71].
Similarly, CEUS with LevovistTM was also found supe-
rior to the unenhanced color Doppler technique, show-
ing excellent agreement with interventional angiography
Fig. 10. Images from a
40-year-old male with
suspected renal colic.
Coronal CECT (A) shows a
giant branch renal artery
pseudoaneurysm (arrow)
which was coil embolized
(B). Post-procedural follow-
up CEUS image
(C) demonstrates the
absence of microbubble
ultrasound contrast within
the aneurysm sac (arrow) in
keeping with complete
occlusion of the
pseudoaneurysm. Grey-
scale image shows
echogenic thrombus within
the pseudoaneurysm (D,
arrow).
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for grading renal artery stenosis [72]. Evaluation of renal
parenchyma perfusion with CEUS is superior to the
unenhanced color Doppler technique and almost equiv-
alent to contrast-enhanced CT, based on the increased
tissue contrast achieved between viable and ischemic
tissue, primarily a consequence of the truly intravascular
nature of the UCA [1, 58]. Renal parenchymal infarction
appears on CEUS as hypoechoic non-enhancing wedge-
shaped areas, readily differentiated from cortical necrosis
[1, 59] (Fig. 11).
The use of UCA for the evaluation of other aortic
branches is limited to the superior and inferior mesen-
teric artery. DeﬁnityTM (Lantheus Medical Imaging,
Billerica, Massachusetts) offers increased sensitivity for
the identiﬁcation of celiac and mesenteric artery stenosis
and occlusion [73]. Others have investigated the use of
UCA for evaluation of mesenteric transit time in Crohn’s
disease, and even though visual and software-based
assessment of the time of maximum UCA enhancement
in the superior mesenteric artery and vein correlated well,
there was no significant correlation with disease activity
[74].
CEUS has also been used to detect liver metastasis by
evaluating hepatic artery and vein enhancement based on
the arrival times to hepatic artery and vein and transit
time between artery and vein; shorter with an increased
level of enhancement in both vessels in patients with liver
metastases. Based on these results, a functional ultra-
sonographic technique performed with only 0.6 mL of
SonoVueTM can be used to detect micrometastases in the
liver [75].
Conclusion
The introduction of UCA has signiﬁcantly expanded the
role of US in the investigation of abdominal vascular
diseases. CEUS is superior to conventional US tech-
niques in term of tissue contrast, spatial, and temporal
resolution and its dynamic and real-time nature in
assessment of tissue perfusion and vascular lumen
opaciﬁcation. Experience has shown that CEUS plays a
key role in certain clinical scenarios such as evaluation of
abdominal trauma, diagnosis of organ ischemia, imaging
surveillance of post-EVAR aorta or the differential
diagnosis of malignant vs. benign portal vein thrombosis
in patients with liver cirrhosis and hepatocellular carci-
noma. CEUS is also useful in assisting ultrasonographic
evaluation of other blood vessels, although the wide-
spread availability of CTA and MRA has limited its role
in the renal arteries and mesenteric arteries.
Fig. 11. Imaging findings
in a patient with renal
infarction. Oblique sagittal
MDCTA image (A) showing
the kidney in long-axis,
revealed the presence of an
upper pole renal infarct
(arrowheads). On follow-up
US, long-axis B-mode
technique (B) did not
visualize any significant
alterations in parenchymal
echogenicity. Respective
color Doppler technique
image (C) demonstrated
less blood flow signals on
the upper half of the kidney
(arrowheads), in keeping
with the infarct. Respective
CEUS image (D) readily
confirmed the diagnosis of
renal infarction
(arrowheads).
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